PTEN and cancer: Deregulation of the PI3K/AKT/mTOR signaling pathway by either the mutation or amplification of genes involved in the PI3K pathway, loss of the tumor suppressor PTEN, or overactivation of RTKs, has been observed in various cancer cells, contributing to tumor progression and metastasis [48,49,50,51].